Drug regulation and approval - A to Z

Drug regulation and approval is a sub-category of Policy

• Our policy on cancer drugs

• Our policy on improving the NICE process

• News story: Clarity over Cancer Drugs Fund should be 'a priority'
  4 April 2013
• News story: Drug approval process in Scotland under review
  15 November 2012
• News story: 18,500 patients receive treatment through Cancer Drugs Fund
  30 August 2012
• News story: NICE recommends new targeted lung cancer treatment
  10 May 2012
• Press Release: Cancer Research UK welcomes prostate cancer drug approval in Wales
  20 February 2012
• News story: Advanced skin cancer drug 'not cost-effective' for NHS
  14 October 2011
• News story: NICE recommends azacitidine for myelodysplastic syndromes
  24 March 2011
• News story: NICE recommends bortezomib and thalidomide for multiple myeloma
  26 August 2010
• News story: Report shows cost-sharing money not getting through
  29 July 2010
• News story: NICE rejects lapatinib for advanced breast cancer
  10 June 2010

• News story: MPs criticise lack of clarity on new drug pricing system
  16 January 2013
• News story: NICE recommends new treatments for advanced melanoma
  2 November 2012
• News story: NICE says 'no' to Avastin for advanced breast cancer
  22 August 2012
• Press Release: Patients lose out as prostate cancer drug is turned down by SMC
  12 March 2012
• News story: Some health trusts 'banning costly cancer drugs', says investigation
  24 November 2011
• News story: Prostate cancer drug abiraterone launched in UK
  21 September 2011
• News story: New £50m fund to improve drug access for cancer patients
  1 October 2010
• News story: NICE draft guidance rejects bevacizumab for advanced bowel cancer
  24 August 2010
• News story: £50m interim fund to improve access to cancer drugs
  27 July 2010
• News story: People with rarer cancers 'still denied access to treatments'
  17 March 2010

• February 2012 podcast
• May 2008 podcast

• September 2008 podcast